Literature DB >> 1087288

A comparison of physical and cytogenetic estimates of radiation dose in patients treated with iodine-131 for thyroid carcinoma.

D C Llloyd, R J Purrott, G W Dolphin, P W Horton, K E Halnan, J S Scott, G Mair.   

Abstract

Physical and cytogenetic estimates of the whole-body radiation doses have been compared in 11 patients receiving large doses of iodine-131 for the treatment of thyroid carcinoma. The physical estimate was based on the measurement of thyroid uptake, of the plasma activity variation, and of urinary activity. The cytogenetic estimate was obtained from the analysis of chromosome aberrations in peripheral blood lymphocytes. Good agreement between the estimates was observed in patients whose thyroid glands had previously been ablated by radioiodine. In patients who had varying degrees of thyroid function, there were considerable differences between the estimates with the cytogenetic value always being higher. It is suggested that these differences might be due in part to non-uniform irradiation of lymphocytes by local sources of activity in the thyroid and in the liver.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087288     DOI: 10.1080/09553007614551291

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  3 in total

Review 1.  Radiation-induced chromosome damage in human lymphocytes.

Authors:  D C Lloyd; G W Dolphin
Journal:  Br J Ind Med       Date:  1977-11

2.  Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.

Authors:  Igor K Khvostunov; Vladimir A Saenko; Valeri Krylov; Andrei Rodichev; Shunichi Yamashita
Journal:  Radiat Environ Biophys       Date:  2017-05-19       Impact factor: 1.925

3.  Estimation of whole-body radiation exposure from brachytherapy for oral cancer using a Monte Carlo simulation.

Authors:  Y Ozaki; H Watanabe; A Kaida; M Miura; K Nakagawa; K Toda; R Yoshimura; Y Sumi; T Kurabayashi
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.